Skip to main content
Clinical Trials/NCT01049321
NCT01049321
Completed
Phase 4

The Effect of DASH Diet on the Cardiometabolic Risks and Hepatic Function Among Type 2 Diabetic Patients

Isfahan University of Medical Sciences1 site in 1 country36 target enrollmentDecember 2008

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Type 2 Diabetic Patients
Sponsor
Isfahan University of Medical Sciences
Enrollment
36
Locations
1
Primary Endpoint
Cardio-metabolic risks
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The investigators are not aware of any study regarding the effect of DASH eating pattern on different cardiovascular risks among type 2 diabetic patients. The investigators assumed that DASH eating pattern could reduce the cardio-metabolic risks and improve the hepatic function among type 2 diabetes.

Registry
clinicaltrials.gov
Start Date
December 2008
End Date
December 2009
Last Updated
16 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Having type 2 diabetes

Exclusion Criteria

  • Having other chronic disease, hepatic or kidney disorders, cancer, hormone therapy

Outcomes

Primary Outcomes

Cardio-metabolic risks

Time Frame: 6 months

Secondary Outcomes

  • Hepatic function(6 months)

Study Sites (1)

Loading locations...

Similar Trials